公司資料
BCR 股價、新聞與催化劑
- 股票代碼:
- BCR
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for BCR.
公司概覽
業務概覽
C. R. Bard was a medical technology company with broad exposure to vascular, urology, and surgical products before being acquired by Becton Dickinson. It represented a durable device and procedure-driven healthcare franchise.
所在地與產業分類
Bard was headquartered in the United States and traded on NYSE before the acquisition. Its business was rooted in medical devices rather than biotech or pharma.
商業模式特徵
The company generated revenue through procedure-linked products, hospital adoption, and recurring device demand. Investors historically watched product cycles, hospital purchasing, and the stability of its surgical and vascular franchise.
生技產業定位
Bard was outside biotech and closer to the medtech infrastructure layer. Since it was acquired, it is best treated as a historical healthcare infrastructure name.
未來催化劑
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。